CHRISTINE DOBRASZ: Open Payments
NPI 1205186145 · NIAGARA FALLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,067 in 89 payments from 19 companies in 2025. Trend: 2023 $1,810 · 2024 $1,408 · 2025 $2,067
Food & beverage: $1,927Education: $114Consulting: $26
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $575 |
| AstraZeneca Pharmaceuticals LP | 20 | $546 |
| GlaxoSmithKline, LLC. | 11 | $213 |
| Amgen Inc. | 5 | $105 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $103 |
| GENZYME CORPORATION | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $65 |
| Insulet Corporation | 2 | $50 |
| Ionis Pharmaceuticals, Inc. | 2 | $45 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, NUCALA, NEFFY, AIRSUPRA, TRELEGY ELLIPTA, Omnipod.
Industry payments across NY — which companies pay providers there.
